| Term 
 
        | Adverse effects: Respiratory depression, Apnea, Paradoxical agitation |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Adverse effects: -Adrenal insufficiency - Pain on injection - Myoclonic activity |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Adverse effects: - Increased BP - Increased HR - Increased Intra-ocular pressure |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Adverse Effects: - Hypotension - Myocardial depression - Reduced cerebral perfusion pressure - Pain on injection |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Adverse Effects: - Hyperkalemia - Muscle fasciculations - Elevated IOP |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Adverse effects: - No clinically significant ADEs |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Dose: 1.5mg/kg IV.  Increase to 2mg/kg IV in myasthenia Gravis 4mg/kg IM (only in life threatening situations) |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | Onset: 60-90 sec Duration: 15-30 min |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Onset: 10-15 sec Duration: 4-10 min  |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Onset: 45-60 sec Duration: 10-20 min |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Onset: 15-45 sec Duration: 5-10 min |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Onset: 45 seconds Duration: 6-10 minutes |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Onset: 60-75 seconds Duration: 40-60 min |  | Definition 
 | 
        |  |